These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23042572)

  • 1. Mechanistic study of the oxidative degradation of the triazole antifungal agent CS-758 in an amorphous form.
    Ueyama E; Suzuki N; Kano K
    J Pharm Sci; 2013 Jan; 102(1):104-13. PubMed ID: 23042572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the oxidative degradation products of an antifungal agent SCH 56592 by LC-NMR and LC-MS.
    Feng W; Liu H; Chen G; Malchow R; Bennett F; Lin E; Pramanik B; Chan TM
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):545-57. PubMed ID: 11377035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of oxidative degradation impurities of olanzapine drug substance as well as drug product.
    Rao PS; Ray UK; Hiriyanna SG; Rao SV; Sharma HK; Handa VK; Mukkanti K
    J Pharm Biomed Anal; 2011 Sep; 56(2):413-8. PubMed ID: 21636234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation kinetics and mechanism of an oxadiazole derivative, design of a stable drug product for BMS-708163, a γ-secretase inhibitor drug candidate.
    Hartley RF; Huang Y; Cassidy M; Razler TM; Qian F; Hussain MA
    J Pharm Sci; 2012 Sep; 101(9):3124-33. PubMed ID: 22262489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of a novel degradant of the antifungal agent posaconazole.
    Zhong W; Yang X; Tong W; Martin GE
    J Pharm Biomed Anal; 2012 Jul; 66():40-9. PubMed ID: 22464557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of liquid chromatography/mass spectrometry and nuclear magnetic resonance to the identification of degradates of a novel insulin sensitizer in aqueous solutions.
    Wang MH; Wu Y; Hwang TL; Qin XZ; Karki S; Treemaneekarn V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):209-19. PubMed ID: 15380717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation.
    Seburg RA; Ballard JM; Hwang TL; Sullivan CM
    J Pharm Biomed Anal; 2006 Oct; 42(4):411-22. PubMed ID: 16787732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
    Singh DK; Sahu A; Handa T; Narayanam M; Singh S
    J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an unusual ring-contraction degradant of the antifungal agent posaconazole.
    Feng W; Hilton BD; Zhong W; Yang J; Yang X; Tong W; Martin GE
    Magn Reson Chem; 2012 Aug; 50(8):576-9. PubMed ID: 22715068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of N-methylpyrrolidone as a cosolvent and oxidant in pharmaceutical stress testing.
    Reynolds DW; Galvani M; Hicks SR; Joshi BJ; Kennedy-Gabb SA; Kleinman MH; Parmar PZ
    J Pharm Sci; 2012 Feb; 101(2):761-76. PubMed ID: 22083665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prediction system of oxidation reaction as a solid-state stress condition: applied to a pyrrole-containing pharmaceutical compound.
    Kawaguchi-Murakami Y; Fukutsu N; Kajiro T; Araki T; Murakami T; Kawasaki T; Kishi N; Konno M
    J Pharm Biomed Anal; 2009 Oct; 50(3):328-35. PubMed ID: 19497698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.
    Hong J; Shah JC; Mcgonagle MD
    J Pharm Sci; 2011 Jul; 100(7):2703-16. PubMed ID: 21283987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of oxidative degradates of the thrombin inhibitor, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methyleneca rboxamidomethylpyridinyl)pyrazinone, using liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry.
    Wu Y; Chen X; Gier L; Almarsson O; Ostovic D; Loper AE
    J Pharm Biomed Anal; 1999 Jul; 20(3):471-85. PubMed ID: 10701963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography/mass spectrometry (LC/MS) identification of photooxidative degradates of crystalline and amorphous MK-912.
    Qin X; Frech P
    J Pharm Sci; 2001 Jul; 90(7):833-44. PubMed ID: 11458333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation.
    Rozman Peterka T; Grahek R; Hren J; Bastarda A; Bergles J; Urleb U
    J Pharm Biomed Anal; 2015 Jun; 110():67-75. PubMed ID: 25804434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural elucidation of two novel degradants of lurasidone and their formation mechanisms under free radical-mediated oxidative and photolytic conditions via liquid chromatography-photodiode array/ultraviolet-tandem mass spectrometry and one-dimensional/two-dimensional nuclear magnetic resonance spectroscopy.
    Wang KC; Guo Q; Kuang Z; Jin J; Li D; Chen W; Zhu W; Li M
    J Mass Spectrom; 2022 Jul; 57(7):e4871. PubMed ID: 35739062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion.
    Wu Y; Hwang TL; Algayer K; Xu W; Wang H; Procopio A; DeBusi L; Yang CY; Matuszewska B
    J Pharm Biomed Anal; 2003 Dec; 33(5):999-1015. PubMed ID: 14656591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of reaction mechanisms of drug degradation in the solid state: a kinetic study implementing ultrahigh-performance liquid chromatography and high-resolution mass spectrometry for thermally stressed thyroxine.
    Neu V; Bielow C; Schneider P; Reinert K; Stuppner H; Huber CG
    Anal Chem; 2013 Feb; 85(4):2385-90. PubMed ID: 23311729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.